European Medicines Agency Okays Experimental Oral Mucositis Drug for Pediatric Investigation
According to a press release from American biotechnology company Soligenix, the European Medicines Agency's (EMA) Pediatric Committee recently agreed to the Company’s Pediatric Investigation Plan (PIP) for experimental oral mucositis…